P&G is seeking new communication methods, new ways of engaging consumers, and ways to create novel brand experiences.
The 2025 MIT Japan Conference will explore future research trends at MIT, highlighting breakthroughs in key areas such as Soft Materials and Mechanics, Biomedical Innovation, and the impact of Generative AI (GAI) on the Work of the Future. Additional sessions will focus on Quantum and Silicon Photonics, Nanotechnology in materials and additive manufacturing, and the latest Machine Learning and AI tools for chemical discovery. Advances in semiconductor technology, hydrogen innovation, and electrochemistry, as well as thermofluidic interfaces, will also be featured.
Please visit the MIT ILP site for the full agenda.
P&G is seeking startups for enabling AI tech: Transforming Consumer Insights Research with IoT, audio, and privacy-preserving video and Synthetic Image and Label Data.
P&G is seeking new advertising and engagement methods, new ways of working without cookies, and ways to create novel brand experiences.
Leading critical environment air quality management company looks for startups in two applications to address market needs resulting from COVID-19.
1. Airborne particulate matter counting and identification
2. New Air Disinfection and Monitoring Technology
Join MIT Startup Exchange to hear from MIT-connected startups who are focusing efforts on scaling up low carbon energy.
Christina Qi, Partner, Domeyard LP
The 2022 MIT Japan Conference will feature presentations by MIT-connected startups in a variety of areas, with technology and business scopes applicable to Japan.
Interpretable AI co-founders, Jack Dunn and Daisy Zhuo
Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]